![J. Christopher Prue](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de J. Christopher Prue
Antiguos cargos conocidos de J. Christopher Prue.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
RANI THERAPEUTICS HOLDINGS, INC. | Consejero General | 01/07/2021 | 01/09/2023 |
AtheroGenics, Inc.
![]() AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Consejero General | - | 14/07/2009 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Consejero General | 10/10/2014 | - |
FLEXION THERAPEUTICS, INC. | Consejero General | 08/05/2014 | - |
The Upjohn Co. | Corporate Officer/Principal | - | - |
Incara Pharmaceuticals Corp. | Corporate Officer/Principal | - | - |
Purdue Pharma LP
![]() Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | - | - |
ABIONYX PHARMA | Consejero General | 24/02/2010 | - |
Formación de J. Christopher Prue.
Purdue University | Undergraduate Degree |
Western Michigan University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 10 |
Francia | 2 |
Operativa
General Counsel | 5 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 9 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ABIONYX PHARMA | Health Technology |
RANI THERAPEUTICS HOLDINGS, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
AtheroGenics, Inc.
![]() AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Purdue Pharma LP
![]() Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
Incara Pharmaceuticals Corp. | Health Technology |
The Upjohn Co. | Health Technology |
Flexion Therapeutics, Inc.
![]() Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
BioDelivery Sciences International, Inc.
![]() BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Bolsa de valores
- Insiders
- J. Christopher Prue
- Experiencia